CD274 and breast cancer: In the present study we exploit a panel of four BC cell lines, representing triple negative breast cancer (TNBC) and ER + types, from both human and mouse species and apply a broad panel of BC small molecule therapeutics to measure the expression of PD-L1 as a result of drug exposure.